comparing to Australia peers other than Greenbush and PLS, Sigma is actually at the better position. Their spod is sold at premium price. Last 20,000t shipment they got 8.75% premium. And their cost is relatively lower. Higher price - lower cost = more profit = more chance of surviving. So their MC (~1.46B AUD) is too low comparing to some other Lithium producers.
There is one major reaon behind that, Sigma was trying to sell, but they had too many issues to stop being sold. One is divorce legal case, another one is Canada's policy. So they have wasted best time to sell. While lot of holders came to gamble of being sold at good price, the management team decided not to sell as situation has big change. I think Sigma is on the path of squeezing these investors out, and these holders' selling push price lower and lower. Looks like a vicious circle. Let's see if the querterly report helps.
From my memory of each producer's cost, I think Greenbush < PLS ~= Sigma < other Australia producers < Canada producers.
To be honest, LRS is in the vicious circle as well. Shorters just used small amount of money to break the resistence and then controlled by robots. The depression makes some investors either panic or impatient, and then joined the queue, pushing down the SP and making another round.
For a 308M MC company with low cost, big single deposit, I feel it's not wise to sell, but my strength is too small. To break this vicious circle, instos need to do something if they want.
- Forums
- Charts
- LRS General Discussion
comparing to Australia peers other than Greenbush and PLS, Sigma...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LRS (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $307.9M |
Open | High | Low | Value | Volume |
12.5¢ | 12.8¢ | 11.0¢ | $2.015M | 17.61M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 2510377 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 491254 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 2425377 | 0.110 |
20 | 2344002 | 0.105 |
46 | 2603359 | 0.100 |
1 | 8060 | 0.099 |
1 | 50000 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 491254 | 8 |
0.120 | 1361659 | 8 |
0.125 | 1725305 | 15 |
0.130 | 764464 | 11 |
0.135 | 851838 | 13 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
LRS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online